Youngstown State slates free start-up workshops

Youngstown State slates free start-up workshops
YOUNGSTOWN -- Youngstown State University's Small Business Development Center is holding free workshops for business start-ups this month and in April. The three-hour workshops are scheduled for 5:30 p.m. Monday, 9 a.m. April 4 and 5:30 p.m. April 18 at the Youngstown Business Incubator on West Federal Street. Registration is required and can be made by calling (330) 746-3350.
NATION/WORLD
Larceny counts stand against former bank broker
NEW YORK -- A state judge said Monday he would let larceny charges stand against a former Bank of America broker accused of illegally profiting by late trading. Theodore Siphol III was accused in a 40-count indictment of stealing more than $1 million from each of six mutual funds by arranging for clients to get the day's closing price even though their trade orders were placed after the 4 p.m. market close. Sihpol, arrested Sept. 16, has pleaded not guilty and is scheduled to go on trial in April. He is free on $750,000 bail. Grand larceny, the top charge against him, carries a penalty of up to 25 years in prison. The other charges are punishable by up to four years each.
11 DaimlerChrysler workers subject of investigation
STUTTGART, Germany -- Prosecutors are investigating 11 people on breach of trust allegations at DaimlerChrysler AG in Germany, a spokeswoman said Monday. The subjects of the investigation involve current mostly sales managers within Germany, German media reported. Focus newsweekly reported that several former managers at the automaker were being investigated for shady deals, including a former Germany sales chief. The magazine reported that he allegedly used company money to build a vacation house for his girlfriend in Spain. The investigations were sparked by anonymous tips of "irregularities" in the German car sales division, said a company spokeswoman.
FDA decides that Crestor can stay on the market
WASHINGTON -- The Food and Drug Administration said Monday it has rejected a petition to remove the cholesterol drug Crestor from the market. Dr. Sidney M. Wolfe of the consumer group Public Citizen petitioned the agency to remove the drug, citing reports of muscle toxicity and kidney damage. FDA said in its response that a review of several studies indicate that AstraZeneca PLC's Crestor does not pose a greater risk of muscle damage than other cholesterol drugs, called statins, on the market.
From Vindicator staff and wire reports